The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Warrants, Issue of Equity & TVR

31 Mar 2022 07:00

RNS Number : 6635G
Asimilar Group PLC
31 March 2022
 

The information contained in this announcement is deemed by the Company to constitute inside information as stipulated under the EU Market Abuse Regulation (596/2014). Upon publication of the announcement via a regulatory information service, this information is considered to be in the public domain.

31 March 2022

 

 

ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')

 

Exercise of 333,333 Warrants, Issue of Equity and Total Voting Rights

 

Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), hereby announces that the Company has received a subscription notice exercising warrants to subscribe for 333,333 new ordinary shares in the Company at a subscription price of 5 pence per share (the "New Shares").

 

166,666 New Shares are being subscribed for by Dewscope Limited, in which Mark Horrocks has a 49% interest, and the remaining 166,667 are being subscribed for by Mr Horrocks' mother, Mrs DJ Horrocks. Following admission of the New Shares, Mr Horrocks interest in the Company, including the shares held by Mrs DJ Horrocks, will be 5,756,280 ordinary shares, representing 4.7% of the Company's enlarged issued share capital.

Application will be made for the admission of the 333,333 New Shares to trading on AIM and it is expected that dealings in the New Shares will commence on or around 5 April 2022. On admission the New Shares will rank pari passu in all respects with the Company's existing ordinary shares.

Total Voting Rights

Following admission of the New Shares the total issued share capital of the Company will consist of 122,257,276 Ordinary Shares, each with voting rights. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Horrocks

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Asimilar Group Plc

b)

LEI

213800AYJZ2B8QNY7H15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.01 pence per share par value 

 

GB00BFX2VL54

b)

Nature of the transaction

Exercise of warrants

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5p

166,666

d)

Aggregated information

-

Aggregated volume

-

Price

 

As above

As above

e)

Date of the transaction

30 March 2022

f)

Place of the transaction

Outside a trading venue

 

-Ends-

Contacts

Asimilar Group plc

John Taylor, Non-Executive Chairman

via Buchanan

Cairn Financial Advisers LLP

Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880

Peterhouse Capital Limited

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

Buchanan Communications Limited

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCURUNRUSUOOAR
Date   Source Headline
23rd Jun 20087:00 amRNSInterim Results
9th Jun 200812:00 pmRNSContract Win
19th Mar 20082:29 pmRNSDirector/PDMR Shareholding
17th Mar 20082:22 pmRNSPosting of annual report
29th Feb 20087:01 amRNSContract gains
27th Feb 20089:27 amRNSHolding(s) in Company
26th Feb 20081:58 pmRNSDirector/PDMR Shareholding
25th Feb 20082:21 pmRNSAGM Statement
6th Feb 20087:01 amRNSAdditional Listing & Placing
31st Jan 20083:35 pmRNSFinal Results
6th Nov 20075:40 pmRNSDirectorate Change
15th Oct 20077:00 amRNSBlue chips trial product
8th Oct 20077:01 amRNSSignificant contract gain
28th Sep 20077:02 amRNSContract Gains
21st Sep 20077:01 amRNSSignificant contract gain
10th Sep 20077:02 amRNSPrivate Placing
17th Aug 20079:07 amRNSRule 26 compliance
13th Aug 20077:00 amRNSContract gains
6th Aug 20077:00 amRNSNew distributor
29th Jun 20077:01 amRNSInterim Results
22nd Jun 20077:01 amRNSContract gains
15th Jun 20077:01 amRNSContract gain
23rd May 20077:01 amRNSBoard Change
14th May 200711:22 amRNSAGM Statement
11th May 20077:01 amRNSNew product launch
23rd Apr 20077:02 amRNSAppointment of Distributors
20th Apr 20075:47 pmRNSDirector/PDMR Shareholding
19th Apr 20077:01 amRNSContract gain
4th Apr 20077:03 amRNSGrowing presence in the USA
29th Mar 200712:15 pmRNSFinal Results
19th Jan 200711:29 amRNSTotal Voting Rights
22nd Dec 200610:06 amRNSTotal Voting Rights
6th Dec 20066:41 pmRNSIssue of Equity
10th Nov 20067:00 amRNSRe Contract
3rd Nov 20067:00 amRNSRe Contract
27th Oct 20067:01 amRNSRe Contract
26th Sep 20061:10 pmRNSIssue of Equity
22nd Sep 20067:00 amRNSContract wins
31st Jul 20067:00 amRNSContract gain
24th Jul 20067:01 amRNSInvestment
15th Jun 20063:05 pmRNSIssue of Equity
14th Jun 20067:01 amRNSInterim Results
6th Jun 20067:01 amRNSContract gain
15th May 200611:37 amRNSDisposal
18th Apr 20067:01 amRNSBoard changes
31st Mar 20063:36 pmRNSAnnual Report and Accounts
31st Mar 200610:37 amRNSFinal Results
24th Feb 20067:00 amRNSCompany Restructure
8th Dec 20057:00 amRNSBahrain office & contract win
25th Nov 20057:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.